Resilience Enhancement Following Sleep Treatment
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT07298941
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Chronic Low Back Pain (CLBP)
- Insomnia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive-behavioral therapy for insomnia (CBTi) — BEHAVIORALSleep Healthy Using the Internet (SHUTi) is a 9-week self-guided, automated, internet-based program that is tailored to the individual and designed to recapitulate the core features of face-to-face CBTi (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relapse prevention). It is fully accessible as a web-based application via computers, tablets, and smartphones.
- CBTi + Savoring Meditation — BEHAVIORALAfter first completing CBTi, participants will then complete a course of Savoring Meditation, a meditation training program focused on generating and maintaining positive emotions. Savoring Meditation training comprises four 30-minute training sessions (20-minute meditation training and 10 minutes for Q\&A and session debrief), and will be delivered 1-on-1 by a trained interventionist over remote video-conference.
- CBTi + Pain Education — BEHAVIORALAfter first completing the full course of CBTi, participants will then complete a Pain Education intervention. Delivered 1-on-1 via telehealth, patients will be introduced to the biopsychosocial model of pain, through which they will learn about 1) biological bases for low back pain and chronic pain in general, 2) psychological and 3) social processes that influence pain perception, and 4) pain self-management strategies that are supported by scientific evidence. Pain Education training comprises four 30-minute training sessions.
Study Details
The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavioral therapy for insomnia (CBTi) program with a meditation intervention (Savoring Meditation) or a Pain Education intervention will result in greater reductions in pain intensity. Secondary objectives include evaluating improvements in insomnia severity, positive and negative affect, and overall quality of life.
Key Dates
- Start date
- Dec 16, 2025
- Status verified
- Dec 2025
- Primary completion
- Oct 30, 2029
- Completion
- Apr 30, 2030
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Other: Cognitive-Behavioral Therapy for InsomniaOpen Label CBTi
- Experimental: Cognitive-Behavioral Therapy for Insomnia plus Savoring MeditationOpen label CBTi followed by random allocation to Savoring Meditation
- Active Comparator: Cognitive-Behavioral Therapy for Insomnia plus Pain EducationOpen label CBTi followed by random allocation to Pain Education
Primary Outcome Measure
Pain Severity [ Time Frame: Baseline to post-intervention (11 weeks) ]
Central Contacts
- Zayn Shahzad434-243-5906
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22903 | Patrick Finan, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
By condition
By specialty
By research site
Related Studies
- Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)PHASE2 · Recruiting · University of Virginia · Charlottesville, Virginia
- A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · New Haven, Connecticut
- Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder SubjectsPHASE2 · Recruiting · Virginia Commonwealth University · Richmond, Virginia
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back PainPHASE3 · Recruiting · Eli Lilly and Company · Chandler, Arizona